The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children in Britain. So-called human challenge trials have been discussed as an alternative option by scientists, whereby vaccinated volunteers are infected intentionally. We are seeing already in Europe the disease is declining," Pascal Soriot told an online press briefing. "Very soon the disease intensity will be low, and it will become difficult, so we have to move very quickly." "We should see the results very soon," Soriot said.

Source: bd News24 May 28, 2020 15:22 UTC